nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—SLCO1B1—Cabazitaxel—prostate cancer	0.115	0.279	CbGbCtD
Acetylcysteine—SLCO1B1—Estrone—prostate cancer	0.113	0.272	CbGbCtD
Acetylcysteine—SLCO1B1—Conjugated Estrogens—prostate cancer	0.0737	0.178	CbGbCtD
Acetylcysteine—SLCO1B1—Estradiol—prostate cancer	0.0647	0.156	CbGbCtD
Acetylcysteine—SLC22A6—Conjugated Estrogens—prostate cancer	0.0474	0.115	CbGbCtD
Acetylcysteine—ACY1—prostate gland—prostate cancer	0.00784	0.101	CbGeAlD
Acetylcysteine—GRIN2D—prostate gland—prostate cancer	0.00555	0.0713	CbGeAlD
Acetylcysteine—CHUK—prostate gland—prostate cancer	0.00541	0.0695	CbGeAlD
Acetylcysteine—ACY1—renal system—prostate cancer	0.00534	0.0687	CbGeAlD
Acetylcysteine—L-Cysteine—CSAD—prostate cancer	0.00505	1	CrCbGaD
Acetylcysteine—CHUK—epithelium—prostate cancer	0.00398	0.0511	CbGeAlD
Acetylcysteine—CHUK—renal system—prostate cancer	0.00369	0.0474	CbGeAlD
Acetylcysteine—IKBKB—prostate gland—prostate cancer	0.00368	0.0473	CbGeAlD
Acetylcysteine—GSS—prostate gland—prostate cancer	0.00361	0.0464	CbGeAlD
Acetylcysteine—ACY1—testis—prostate cancer	0.00345	0.0444	CbGeAlD
Acetylcysteine—GSS—seminal vesicle—prostate cancer	0.00305	0.0392	CbGeAlD
Acetylcysteine—SLC7A11—renal system—prostate cancer	0.00304	0.039	CbGeAlD
Acetylcysteine—IKBKB—urethra—prostate cancer	0.00246	0.0316	CbGeAlD
Acetylcysteine—GSS—renal system—prostate cancer	0.00246	0.0316	CbGeAlD
Acetylcysteine—GRIN2D—testis—prostate cancer	0.00245	0.0314	CbGeAlD
Acetylcysteine—GSS—urethra—prostate cancer	0.00242	0.0311	CbGeAlD
Acetylcysteine—CHUK—testis—prostate cancer	0.00238	0.0306	CbGeAlD
Acetylcysteine—GRIN3A—testis—prostate cancer	0.0023	0.0295	CbGeAlD
Acetylcysteine—SLC7A11—testis—prostate cancer	0.00196	0.0252	CbGeAlD
Acetylcysteine—GSS—bone marrow—prostate cancer	0.00186	0.0239	CbGeAlD
Acetylcysteine—GRIN2A—testis—prostate cancer	0.00182	0.0234	CbGeAlD
Acetylcysteine—SLCO1B1—renal system—prostate cancer	0.00181	0.0232	CbGeAlD
Acetylcysteine—CHUK—lymph node—prostate cancer	0.00173	0.0222	CbGeAlD
Acetylcysteine—IKBKB—testis—prostate cancer	0.00162	0.0208	CbGeAlD
Acetylcysteine—GSS—testis—prostate cancer	0.00159	0.0204	CbGeAlD
Acetylcysteine—IKBKB—lymph node—prostate cancer	0.00117	0.0151	CbGeAlD
Acetylcysteine—GSS—lymph node—prostate cancer	0.00115	0.0148	CbGeAlD
Acetylcysteine—SLC7A11—Betamethasone—Prednisone—prostate cancer	0.000933	0.5	CbGdCrCtD
Acetylcysteine—SLC7A11—Dexamethasone—Prednisone—prostate cancer	0.000933	0.5	CbGdCrCtD
Acetylcysteine—Mental disability—Epirubicin—prostate cancer	0.000294	0.0014	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—prostate cancer	0.000288	0.00137	CcSEcCtD
Acetylcysteine—Dizziness—Ethinyl Estradiol—prostate cancer	0.000282	0.00134	CcSEcCtD
Acetylcysteine—Flushing—Etoposide—prostate cancer	0.000282	0.00134	CcSEcCtD
Acetylcysteine—Cardiac disorder—Etoposide—prostate cancer	0.000282	0.00134	CcSEcCtD
Acetylcysteine—Urticaria—Goserelin—prostate cancer	0.000279	0.00133	CcSEcCtD
Acetylcysteine—Oedema—Estradiol—prostate cancer	0.000278	0.00132	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Estradiol—prostate cancer	0.000278	0.00132	CcSEcCtD
Acetylcysteine—Body temperature increased—Goserelin—prostate cancer	0.000277	0.00132	CcSEcCtD
Acetylcysteine—Cough—Mitoxantrone—prostate cancer	0.000277	0.00132	CcSEcCtD
Acetylcysteine—Urticaria—Conjugated Estrogens—prostate cancer	0.000276	0.00132	CcSEcCtD
Acetylcysteine—Angiopathy—Etoposide—prostate cancer	0.000275	0.00131	CcSEcCtD
Acetylcysteine—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000275	0.00131	CcSEcCtD
Acetylcysteine—Immune system disorder—Etoposide—prostate cancer	0.000274	0.00131	CcSEcCtD
Acetylcysteine—Stomatitis—Docetaxel—prostate cancer	0.000274	0.0013	CcSEcCtD
Acetylcysteine—Shock—Estradiol—prostate cancer	0.000274	0.0013	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Etoposide—prostate cancer	0.000273	0.0013	CcSEcCtD
Acetylcysteine—Eye pain—Epirubicin—prostate cancer	0.000272	0.0013	CcSEcCtD
Acetylcysteine—Mental disability—Doxorubicin—prostate cancer	0.000272	0.0013	CcSEcCtD
Acetylcysteine—Tachycardia—Estradiol—prostate cancer	0.000271	0.00129	CcSEcCtD
Acetylcysteine—Vomiting—Ethinyl Estradiol—prostate cancer	0.000271	0.00129	CcSEcCtD
Acetylcysteine—Skin disorder—Estradiol—prostate cancer	0.00027	0.00129	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Estradiol—prostate cancer	0.000269	0.00128	CcSEcCtD
Acetylcysteine—Rash—Ethinyl Estradiol—prostate cancer	0.000269	0.00128	CcSEcCtD
Acetylcysteine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000269	0.00128	CcSEcCtD
Acetylcysteine—Stomatitis—Capecitabine—prostate cancer	0.000265	0.00126	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Mitoxantrone—prostate cancer	0.000259	0.00123	CcSEcCtD
Acetylcysteine—Oedema—Mitoxantrone—prostate cancer	0.000259	0.00123	CcSEcCtD
Acetylcysteine—Hypersensitivity—Goserelin—prostate cancer	0.000258	0.00123	CcSEcCtD
Acetylcysteine—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000256	0.00122	CcSEcCtD
Acetylcysteine—Shock—Mitoxantrone—prostate cancer	0.000255	0.00121	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Epirubicin—prostate cancer	0.000254	0.00121	CcSEcCtD
Acetylcysteine—Nausea—Ethinyl Estradiol—prostate cancer	0.000253	0.00121	CcSEcCtD
Acetylcysteine—Tachycardia—Mitoxantrone—prostate cancer	0.000253	0.0012	CcSEcCtD
Acetylcysteine—Eye pain—Doxorubicin—prostate cancer	0.000252	0.0012	CcSEcCtD
Acetylcysteine—Skin disorder—Mitoxantrone—prostate cancer	0.000252	0.0012	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000251	0.00119	CcSEcCtD
Acetylcysteine—Pharyngitis—Docetaxel—prostate cancer	0.00025	0.00119	CcSEcCtD
Acetylcysteine—Pruritus—Goserelin—prostate cancer	0.000248	0.00118	CcSEcCtD
Acetylcysteine—Dyspnoea—Estradiol—prostate cancer	0.000248	0.00118	CcSEcCtD
Acetylcysteine—Somnolence—Estradiol—prostate cancer	0.000247	0.00118	CcSEcCtD
Acetylcysteine—Pruritus—Conjugated Estrogens—prostate cancer	0.000246	0.00117	CcSEcCtD
Acetylcysteine—Dyspepsia—Estradiol—prostate cancer	0.000245	0.00117	CcSEcCtD
Acetylcysteine—Pharyngitis—Capecitabine—prostate cancer	0.000242	0.00115	CcSEcCtD
Acetylcysteine—Hypotension—Mitoxantrone—prostate cancer	0.000242	0.00115	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Estradiol—prostate cancer	0.00024	0.00114	CcSEcCtD
Acetylcysteine—Face oedema—Epirubicin—prostate cancer	0.000237	0.00113	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Doxorubicin—prostate cancer	0.000235	0.00112	CcSEcCtD
Acetylcysteine—Flushing—Docetaxel—prostate cancer	0.000234	0.00111	CcSEcCtD
Acetylcysteine—Cardiac disorder—Docetaxel—prostate cancer	0.000234	0.00111	CcSEcCtD
Acetylcysteine—Loss of consciousness—Etoposide—prostate cancer	0.000232	0.00111	CcSEcCtD
Acetylcysteine—Dizziness—Goserelin—prostate cancer	0.000232	0.00111	CcSEcCtD
Acetylcysteine—Dyspnoea—Mitoxantrone—prostate cancer	0.000231	0.0011	CcSEcCtD
Acetylcysteine—Cough—Etoposide—prostate cancer	0.00023	0.0011	CcSEcCtD
Acetylcysteine—Somnolence—Mitoxantrone—prostate cancer	0.00023	0.0011	CcSEcCtD
Acetylcysteine—Dizziness—Conjugated Estrogens—prostate cancer	0.00023	0.00109	CcSEcCtD
Acetylcysteine—Angiopathy—Docetaxel—prostate cancer	0.000229	0.00109	CcSEcCtD
Acetylcysteine—Dyspepsia—Mitoxantrone—prostate cancer	0.000228	0.00109	CcSEcCtD
Acetylcysteine—Immune system disorder—Docetaxel—prostate cancer	0.000228	0.00108	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Docetaxel—prostate cancer	0.000227	0.00108	CcSEcCtD
Acetylcysteine—Flushing—Capecitabine—prostate cancer	0.000227	0.00108	CcSEcCtD
Acetylcysteine—Cardiac disorder—Capecitabine—prostate cancer	0.000227	0.00108	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000223	0.00106	CcSEcCtD
Acetylcysteine—Vomiting—Goserelin—prostate cancer	0.000223	0.00106	CcSEcCtD
Acetylcysteine—Angiopathy—Capecitabine—prostate cancer	0.000221	0.00106	CcSEcCtD
Acetylcysteine—Rash—Goserelin—prostate cancer	0.000221	0.00105	CcSEcCtD
Acetylcysteine—Dermatitis—Goserelin—prostate cancer	0.000221	0.00105	CcSEcCtD
Acetylcysteine—Vomiting—Conjugated Estrogens—prostate cancer	0.000221	0.00105	CcSEcCtD
Acetylcysteine—Urticaria—Estradiol—prostate cancer	0.000221	0.00105	CcSEcCtD
Acetylcysteine—Immune system disorder—Capecitabine—prostate cancer	0.000221	0.00105	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Capecitabine—prostate cancer	0.00022	0.00105	CcSEcCtD
Acetylcysteine—Body temperature increased—Estradiol—prostate cancer	0.00022	0.00105	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Epirubicin—prostate cancer	0.00022	0.00105	CcSEcCtD
Acetylcysteine—Face oedema—Doxorubicin—prostate cancer	0.00022	0.00105	CcSEcCtD
Acetylcysteine—Erythema—Docetaxel—prostate cancer	0.000219	0.00105	CcSEcCtD
Acetylcysteine—Rash—Conjugated Estrogens—prostate cancer	0.000219	0.00104	CcSEcCtD
Acetylcysteine—Dermatitis—Conjugated Estrogens—prostate cancer	0.000219	0.00104	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Etoposide—prostate cancer	0.000216	0.00103	CcSEcCtD
Acetylcysteine—Erythema—Capecitabine—prostate cancer	0.000213	0.00101	CcSEcCtD
Acetylcysteine—Asthma—Epirubicin—prostate cancer	0.000212	0.00101	CcSEcCtD
Acetylcysteine—Tachycardia—Etoposide—prostate cancer	0.00021	0.001	CcSEcCtD
Acetylcysteine—Skin disorder—Etoposide—prostate cancer	0.000209	0.000997	CcSEcCtD
Acetylcysteine—Nausea—Goserelin—prostate cancer	0.000208	0.000993	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Etoposide—prostate cancer	0.000208	0.000993	CcSEcCtD
Acetylcysteine—Nausea—Conjugated Estrogens—prostate cancer	0.000206	0.000983	CcSEcCtD
Acetylcysteine—Urticaria—Mitoxantrone—prostate cancer	0.000206	0.000981	CcSEcCtD
Acetylcysteine—Hypersensitivity—Estradiol—prostate cancer	0.000205	0.000976	CcSEcCtD
Acetylcysteine—Body temperature increased—Mitoxantrone—prostate cancer	0.000205	0.000976	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Doxorubicin—prostate cancer	0.000203	0.000969	CcSEcCtD
Acetylcysteine—Flushing—Prednisone—prostate cancer	0.000202	0.000961	CcSEcCtD
Acetylcysteine—Hypotension—Etoposide—prostate cancer	0.000201	0.000959	CcSEcCtD
Acetylcysteine—Angiopathy—Prednisone—prostate cancer	0.000197	0.00094	CcSEcCtD
Acetylcysteine—Syncope—Docetaxel—prostate cancer	0.000197	0.000938	CcSEcCtD
Acetylcysteine—Pruritus—Estradiol—prostate cancer	0.000197	0.000937	CcSEcCtD
Acetylcysteine—Asthma—Doxorubicin—prostate cancer	0.000197	0.000936	CcSEcCtD
Acetylcysteine—Immune system disorder—Prednisone—prostate cancer	0.000196	0.000936	CcSEcCtD
Acetylcysteine—Loss of consciousness—Docetaxel—prostate cancer	0.000193	0.000919	CcSEcCtD
Acetylcysteine—Dyspnoea—Etoposide—prostate cancer	0.000192	0.000915	CcSEcCtD
Acetylcysteine—Somnolence—Etoposide—prostate cancer	0.000192	0.000913	CcSEcCtD
Acetylcysteine—Cough—Docetaxel—prostate cancer	0.000192	0.000912	CcSEcCtD
Acetylcysteine—Hypersensitivity—Mitoxantrone—prostate cancer	0.000191	0.000909	CcSEcCtD
Acetylcysteine—Syncope—Capecitabine—prostate cancer	0.000191	0.000908	CcSEcCtD
Acetylcysteine—Drowsiness—Epirubicin—prostate cancer	0.000189	0.000902	CcSEcCtD
Acetylcysteine—Erythema—Prednisone—prostate cancer	0.000189	0.000902	CcSEcCtD
Acetylcysteine—Loss of consciousness—Capecitabine—prostate cancer	0.000187	0.00089	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Etoposide—prostate cancer	0.000186	0.000886	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000186	0.000884	CcSEcCtD
Acetylcysteine—Cough—Capecitabine—prostate cancer	0.000185	0.000883	CcSEcCtD
Acetylcysteine—Stomatitis—Epirubicin—prostate cancer	0.000185	0.00088	CcSEcCtD
Acetylcysteine—Dizziness—Estradiol—prostate cancer	0.000184	0.000876	CcSEcCtD
Acetylcysteine—Sweating—Epirubicin—prostate cancer	0.000182	0.000865	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.00018	0.000856	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Docetaxel—prostate cancer	0.000179	0.000853	CcSEcCtD
Acetylcysteine—Oedema—Docetaxel—prostate cancer	0.000179	0.000853	CcSEcCtD
Acetylcysteine—Vomiting—Estradiol—prostate cancer	0.000177	0.000842	CcSEcCtD
Acetylcysteine—Shock—Docetaxel—prostate cancer	0.000176	0.00084	CcSEcCtD
Acetylcysteine—Rash—Estradiol—prostate cancer	0.000175	0.000835	CcSEcCtD
Acetylcysteine—Drowsiness—Doxorubicin—prostate cancer	0.000175	0.000835	CcSEcCtD
Acetylcysteine—Dermatitis—Estradiol—prostate cancer	0.000175	0.000835	CcSEcCtD
Acetylcysteine—Tachycardia—Docetaxel—prostate cancer	0.000175	0.000833	CcSEcCtD
Acetylcysteine—Skin disorder—Docetaxel—prostate cancer	0.000174	0.000829	CcSEcCtD
Acetylcysteine—Oedema—Capecitabine—prostate cancer	0.000173	0.000826	CcSEcCtD
Acetylcysteine—Angioedema—Prednisone—prostate cancer	0.000173	0.000824	CcSEcCtD
Acetylcysteine—Urticaria—Etoposide—prostate cancer	0.000171	0.000816	CcSEcCtD
Acetylcysteine—Stomatitis—Doxorubicin—prostate cancer	0.000171	0.000814	CcSEcCtD
Acetylcysteine—Shock—Capecitabine—prostate cancer	0.000171	0.000813	CcSEcCtD
Acetylcysteine—Body temperature increased—Etoposide—prostate cancer	0.00017	0.000812	CcSEcCtD
Acetylcysteine—Syncope—Prednisone—prostate cancer	0.00017	0.000809	CcSEcCtD
Acetylcysteine—Tachycardia—Capecitabine—prostate cancer	0.000169	0.000806	CcSEcCtD
Acetylcysteine—Pharyngitis—Epirubicin—prostate cancer	0.000169	0.000804	CcSEcCtD
Acetylcysteine—Skin disorder—Capecitabine—prostate cancer	0.000168	0.000802	CcSEcCtD
Acetylcysteine—Sweating—Doxorubicin—prostate cancer	0.000168	0.0008	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Capecitabine—prostate cancer	0.000168	0.000799	CcSEcCtD
Acetylcysteine—Hypotension—Docetaxel—prostate cancer	0.000167	0.000797	CcSEcCtD
Acetylcysteine—Loss of consciousness—Prednisone—prostate cancer	0.000166	0.000793	CcSEcCtD
Acetylcysteine—Nausea—Estradiol—prostate cancer	0.000165	0.000787	CcSEcCtD
Acetylcysteine—Vomiting—Mitoxantrone—prostate cancer	0.000165	0.000785	CcSEcCtD
Acetylcysteine—Rash—Mitoxantrone—prostate cancer	0.000163	0.000778	CcSEcCtD
Acetylcysteine—Dermatitis—Mitoxantrone—prostate cancer	0.000163	0.000778	CcSEcCtD
Acetylcysteine—Hypotension—Capecitabine—prostate cancer	0.000162	0.000772	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.00016	0.000762	CcSEcCtD
Acetylcysteine—Dyspnoea—Docetaxel—prostate cancer	0.00016	0.000761	CcSEcCtD
Acetylcysteine—Somnolence—Docetaxel—prostate cancer	0.000159	0.000759	CcSEcCtD
Acetylcysteine—Hypersensitivity—Etoposide—prostate cancer	0.000159	0.000756	CcSEcCtD
Acetylcysteine—Flushing—Epirubicin—prostate cancer	0.000158	0.000752	CcSEcCtD
Acetylcysteine—Cardiac disorder—Epirubicin—prostate cancer	0.000158	0.000752	CcSEcCtD
Acetylcysteine—Dyspepsia—Docetaxel—prostate cancer	0.000158	0.000751	CcSEcCtD
Acetylcysteine—Pharyngitis—Doxorubicin—prostate cancer	0.000156	0.000744	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000155	0.000737	CcSEcCtD
Acetylcysteine—Dyspnoea—Capecitabine—prostate cancer	0.000155	0.000737	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Prednisone—prostate cancer	0.000154	0.000736	CcSEcCtD
Acetylcysteine—Oedema—Prednisone—prostate cancer	0.000154	0.000736	CcSEcCtD
Acetylcysteine—Angiopathy—Epirubicin—prostate cancer	0.000154	0.000735	CcSEcCtD
Acetylcysteine—Nausea—Mitoxantrone—prostate cancer	0.000154	0.000733	CcSEcCtD
Acetylcysteine—Immune system disorder—Epirubicin—prostate cancer	0.000154	0.000732	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Epirubicin—prostate cancer	0.000153	0.00073	CcSEcCtD
Acetylcysteine—Dyspepsia—Capecitabine—prostate cancer	0.000153	0.000727	CcSEcCtD
Acetylcysteine—Pruritus—Etoposide—prostate cancer	0.000153	0.000726	CcSEcCtD
Acetylcysteine—Shock—Prednisone—prostate cancer	0.000152	0.000724	CcSEcCtD
Acetylcysteine—Tachycardia—Prednisone—prostate cancer	0.000151	0.000718	CcSEcCtD
Acetylcysteine—Skin disorder—Prednisone—prostate cancer	0.00015	0.000715	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Capecitabine—prostate cancer	0.00015	0.000713	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Prednisone—prostate cancer	0.000149	0.000711	CcSEcCtD
Acetylcysteine—Erythema—Epirubicin—prostate cancer	0.000148	0.000705	CcSEcCtD
Acetylcysteine—Flushing—Doxorubicin—prostate cancer	0.000146	0.000696	CcSEcCtD
Acetylcysteine—Cardiac disorder—Doxorubicin—prostate cancer	0.000146	0.000696	CcSEcCtD
Acetylcysteine—Angiopathy—Doxorubicin—prostate cancer	0.000143	0.00068	CcSEcCtD
Acetylcysteine—Dizziness—Etoposide—prostate cancer	0.000143	0.000679	CcSEcCtD
Acetylcysteine—Immune system disorder—Doxorubicin—prostate cancer	0.000142	0.000677	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Doxorubicin—prostate cancer	0.000142	0.000676	CcSEcCtD
Acetylcysteine—Body temperature increased—Docetaxel—prostate cancer	0.000142	0.000675	CcSEcCtD
Acetylcysteine—Urticaria—Capecitabine—prostate cancer	0.000138	0.000656	CcSEcCtD
Acetylcysteine—Body temperature increased—Capecitabine—prostate cancer	0.000137	0.000653	CcSEcCtD
Acetylcysteine—Vomiting—Etoposide—prostate cancer	0.000137	0.000653	CcSEcCtD
Acetylcysteine—Erythema—Doxorubicin—prostate cancer	0.000137	0.000653	CcSEcCtD
Acetylcysteine—Dyspepsia—Prednisone—prostate cancer	0.000136	0.000648	CcSEcCtD
Acetylcysteine—Rash—Etoposide—prostate cancer	0.000136	0.000647	CcSEcCtD
Acetylcysteine—Dermatitis—Etoposide—prostate cancer	0.000136	0.000647	CcSEcCtD
Acetylcysteine—Syncope—Epirubicin—prostate cancer	0.000133	0.000632	CcSEcCtD
Acetylcysteine—Hypersensitivity—Docetaxel—prostate cancer	0.000132	0.000629	CcSEcCtD
Acetylcysteine—Loss of consciousness—Epirubicin—prostate cancer	0.00013	0.00062	CcSEcCtD
Acetylcysteine—Cough—Epirubicin—prostate cancer	0.000129	0.000615	CcSEcCtD
Acetylcysteine—Nausea—Etoposide—prostate cancer	0.000128	0.00061	CcSEcCtD
Acetylcysteine—Hypersensitivity—Capecitabine—prostate cancer	0.000128	0.000609	CcSEcCtD
Acetylcysteine—Pruritus—Docetaxel—prostate cancer	0.000127	0.000604	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000125	0.000596	CcSEcCtD
Acetylcysteine—Syncope—Doxorubicin—prostate cancer	0.000123	0.000585	CcSEcCtD
Acetylcysteine—Urticaria—Prednisone—prostate cancer	0.000123	0.000585	CcSEcCtD
Acetylcysteine—Pruritus—Capecitabine—prostate cancer	0.000123	0.000585	CcSEcCtD
Acetylcysteine—Body temperature increased—Prednisone—prostate cancer	0.000122	0.000582	CcSEcCtD
Acetylcysteine—Oedema—Epirubicin—prostate cancer	0.000121	0.000576	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Epirubicin—prostate cancer	0.000121	0.000576	CcSEcCtD
Acetylcysteine—Loss of consciousness—Doxorubicin—prostate cancer	0.00012	0.000574	CcSEcCtD
Acetylcysteine—Cough—Doxorubicin—prostate cancer	0.00012	0.000569	CcSEcCtD
Acetylcysteine—Shock—Epirubicin—prostate cancer	0.000119	0.000566	CcSEcCtD
Acetylcysteine—Dizziness—Docetaxel—prostate cancer	0.000118	0.000564	CcSEcCtD
Acetylcysteine—Tachycardia—Epirubicin—prostate cancer	0.000118	0.000562	CcSEcCtD
Acetylcysteine—Skin disorder—Epirubicin—prostate cancer	0.000117	0.000559	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Epirubicin—prostate cancer	0.000117	0.000556	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000116	0.000552	CcSEcCtD
Acetylcysteine—Dizziness—Capecitabine—prostate cancer	0.000115	0.000546	CcSEcCtD
Acetylcysteine—Vomiting—Docetaxel—prostate cancer	0.000114	0.000543	CcSEcCtD
Acetylcysteine—Hypersensitivity—Prednisone—prostate cancer	0.000114	0.000542	CcSEcCtD
Acetylcysteine—Rash—Docetaxel—prostate cancer	0.000113	0.000538	CcSEcCtD
Acetylcysteine—Hypotension—Epirubicin—prostate cancer	0.000113	0.000538	CcSEcCtD
Acetylcysteine—Dermatitis—Docetaxel—prostate cancer	0.000113	0.000538	CcSEcCtD
Acetylcysteine—Oedema—Doxorubicin—prostate cancer	0.000112	0.000533	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Doxorubicin—prostate cancer	0.000112	0.000533	CcSEcCtD
Acetylcysteine—Vomiting—Capecitabine—prostate cancer	0.00011	0.000525	CcSEcCtD
Acetylcysteine—Shock—Doxorubicin—prostate cancer	0.00011	0.000524	CcSEcCtD
Acetylcysteine—Rash—Capecitabine—prostate cancer	0.000109	0.000521	CcSEcCtD
Acetylcysteine—Pruritus—Prednisone—prostate cancer	0.000109	0.000521	CcSEcCtD
Acetylcysteine—Dermatitis—Capecitabine—prostate cancer	0.000109	0.00052	CcSEcCtD
Acetylcysteine—Tachycardia—Doxorubicin—prostate cancer	0.000109	0.00052	CcSEcCtD
Acetylcysteine—Skin disorder—Doxorubicin—prostate cancer	0.000109	0.000517	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Doxorubicin—prostate cancer	0.000108	0.000515	CcSEcCtD
Acetylcysteine—Dyspnoea—Epirubicin—prostate cancer	0.000108	0.000513	CcSEcCtD
Acetylcysteine—Somnolence—Epirubicin—prostate cancer	0.000107	0.000512	CcSEcCtD
Acetylcysteine—Nausea—Docetaxel—prostate cancer	0.000106	0.000507	CcSEcCtD
Acetylcysteine—Dyspepsia—Epirubicin—prostate cancer	0.000106	0.000507	CcSEcCtD
Acetylcysteine—Hypotension—Doxorubicin—prostate cancer	0.000104	0.000498	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000104	0.000497	CcSEcCtD
Acetylcysteine—Nausea—Capecitabine—prostate cancer	0.000103	0.000491	CcSEcCtD
Acetylcysteine—Dizziness—Prednisone—prostate cancer	0.000102	0.000487	CcSEcCtD
Acetylcysteine—Dyspnoea—Doxorubicin—prostate cancer	9.97e-05	0.000475	CcSEcCtD
Acetylcysteine—Somnolence—Doxorubicin—prostate cancer	9.94e-05	0.000473	CcSEcCtD
Acetylcysteine—Dyspepsia—Doxorubicin—prostate cancer	9.84e-05	0.000469	CcSEcCtD
Acetylcysteine—Vomiting—Prednisone—prostate cancer	9.82e-05	0.000468	CcSEcCtD
Acetylcysteine—Rash—Prednisone—prostate cancer	9.74e-05	0.000464	CcSEcCtD
Acetylcysteine—Dermatitis—Prednisone—prostate cancer	9.73e-05	0.000464	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Doxorubicin—prostate cancer	9.65e-05	0.00046	CcSEcCtD
Acetylcysteine—Urticaria—Epirubicin—prostate cancer	9.6e-05	0.000457	CcSEcCtD
Acetylcysteine—Body temperature increased—Epirubicin—prostate cancer	9.55e-05	0.000455	CcSEcCtD
Acetylcysteine—Nausea—Prednisone—prostate cancer	9.18e-05	0.000437	CcSEcCtD
Acetylcysteine—Hypersensitivity—Epirubicin—prostate cancer	8.9e-05	0.000424	CcSEcCtD
Acetylcysteine—Urticaria—Doxorubicin—prostate cancer	8.88e-05	0.000423	CcSEcCtD
Acetylcysteine—Body temperature increased—Doxorubicin—prostate cancer	8.84e-05	0.000421	CcSEcCtD
Acetylcysteine—Pruritus—Epirubicin—prostate cancer	8.55e-05	0.000407	CcSEcCtD
Acetylcysteine—Hypersensitivity—Doxorubicin—prostate cancer	8.24e-05	0.000392	CcSEcCtD
Acetylcysteine—Dizziness—Epirubicin—prostate cancer	7.99e-05	0.000381	CcSEcCtD
Acetylcysteine—Pruritus—Doxorubicin—prostate cancer	7.91e-05	0.000377	CcSEcCtD
Acetylcysteine—Vomiting—Epirubicin—prostate cancer	7.68e-05	0.000366	CcSEcCtD
Acetylcysteine—Rash—Epirubicin—prostate cancer	7.62e-05	0.000363	CcSEcCtD
Acetylcysteine—Dermatitis—Epirubicin—prostate cancer	7.61e-05	0.000363	CcSEcCtD
Acetylcysteine—Dizziness—Doxorubicin—prostate cancer	7.39e-05	0.000352	CcSEcCtD
Acetylcysteine—Nausea—Epirubicin—prostate cancer	7.18e-05	0.000342	CcSEcCtD
Acetylcysteine—Vomiting—Doxorubicin—prostate cancer	7.11e-05	0.000339	CcSEcCtD
Acetylcysteine—Rash—Doxorubicin—prostate cancer	7.05e-05	0.000336	CcSEcCtD
Acetylcysteine—Dermatitis—Doxorubicin—prostate cancer	7.04e-05	0.000335	CcSEcCtD
Acetylcysteine—Nausea—Doxorubicin—prostate cancer	6.64e-05	0.000316	CcSEcCtD
Acetylcysteine—SLCO1B1—Metabolism—RXRA—prostate cancer	6.73e-06	2.31e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PTEN—prostate cancer	6.72e-06	2.31e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—EGF—prostate cancer	6.71e-06	2.3e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IRS1—prostate cancer	6.71e-06	2.3e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ADRB2—prostate cancer	6.7e-06	2.3e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—TLR4—prostate cancer	6.69e-06	2.29e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—EP300—prostate cancer	6.68e-06	2.29e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CASP9—prostate cancer	6.66e-06	2.29e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	6.55e-06	2.25e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—VAV3—prostate cancer	6.53e-06	2.24e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—GSK3B—prostate cancer	6.52e-06	2.24e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—SRC—prostate cancer	6.49e-06	2.23e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—COMT—prostate cancer	6.49e-06	2.22e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—BAD—prostate cancer	6.48e-06	2.22e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NGFR—prostate cancer	6.46e-06	2.21e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PRKCQ—prostate cancer	6.46e-06	2.21e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GSTP1—prostate cancer	6.46e-06	2.21e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TGFBR2—prostate cancer	6.44e-06	2.21e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—ICAM1—prostate cancer	6.41e-06	2.2e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MAP3K7—prostate cancer	6.38e-06	2.19e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—BAD—prostate cancer	6.36e-06	2.18e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ITPR1—prostate cancer	6.35e-06	2.18e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ITPR1—prostate cancer	6.33e-06	2.17e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CREBBP—prostate cancer	6.3e-06	2.16e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—EGFR—prostate cancer	6.28e-06	2.15e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—APC—prostate cancer	6.27e-06	2.15e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDH1—prostate cancer	6.25e-06	2.14e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	6.25e-06	2.14e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—SRC—prostate cancer	6.24e-06	2.14e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—EGF—prostate cancer	6.2e-06	2.13e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—IRS1—prostate cancer	6.2e-06	2.13e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FGF10—prostate cancer	6.14e-06	2.1e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IRS1—prostate cancer	6.09e-06	2.09e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—EGF—prostate cancer	6.09e-06	2.09e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ADRB2—prostate cancer	6.07e-06	2.08e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IGF1R—prostate cancer	6.06e-06	2.08e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—EGFR—prostate cancer	6.03e-06	2.07e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—GSK3B—prostate cancer	6.02e-06	2.06e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MAP2K1—prostate cancer	6.01e-06	2.06e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—TYMS—prostate cancer	6e-06	2.06e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3CD—prostate cancer	5.97e-06	2.05e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—INS—prostate cancer	5.94e-06	2.04e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GSTM1—prostate cancer	5.93e-06	2.03e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—KRAS—prostate cancer	5.93e-06	2.03e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—VAV3—prostate cancer	5.92e-06	2.03e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—GSK3B—prostate cancer	5.91e-06	2.03e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TGFBR2—prostate cancer	5.84e-06	2e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—LPL—prostate cancer	5.82e-06	2e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CREBBP—prostate cancer	5.81e-06	1.99e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—LPL—prostate cancer	5.81e-06	1.99e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PDGFRB—prostate cancer	5.75e-06	1.97e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ITPR1—prostate cancer	5.74e-06	1.97e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—FGF2—prostate cancer	5.72e-06	1.96e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CREBBP—prostate cancer	5.71e-06	1.96e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—KRAS—prostate cancer	5.69e-06	1.95e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—EGFR—prostate cancer	5.69e-06	1.95e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDH1—prostate cancer	5.67e-06	1.94e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CYP1A1—prostate cancer	5.62e-06	1.93e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ITGB3—prostate cancer	5.61e-06	1.92e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ERCC2—prostate cancer	5.58e-06	1.91e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MAP2K1—prostate cancer	5.55e-06	1.9e-05	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—AKT1—prostate cancer	5.53e-06	1.89e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3CD—prostate cancer	5.51e-06	1.89e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IGF1R—prostate cancer	5.49e-06	1.88e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—JAK2—prostate cancer	5.48e-06	1.88e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—EGFR—prostate cancer	5.47e-06	1.87e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—SERPINE1—prostate cancer	5.45e-06	1.87e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MAP2K1—prostate cancer	5.45e-06	1.87e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—PIK3CA—prostate cancer	5.45e-06	1.87e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ERBB3—prostate cancer	5.44e-06	1.86e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FGFR2—prostate cancer	5.43e-06	1.86e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—BCL2—prostate cancer	5.43e-06	1.86e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3CD—prostate cancer	5.41e-06	1.86e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—KRAS—prostate cancer	5.38e-06	1.84e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MDM2—prostate cancer	5.35e-06	1.83e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—FGF2—prostate cancer	5.28e-06	1.81e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—ERBB2—prostate cancer	5.27e-06	1.81e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—LPL—prostate cancer	5.26e-06	1.81e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—MTHFR—prostate cancer	5.24e-06	1.8e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—PIK3CA—prostate cancer	5.23e-06	1.79e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PDGFRB—prostate cancer	5.22e-06	1.79e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TERT—prostate cancer	5.21e-06	1.79e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NOS3—prostate cancer	5.21e-06	1.79e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3CB—prostate cancer	5.2e-06	1.78e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—FGF2—prostate cancer	5.18e-06	1.78e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—KRAS—prostate cancer	5.16e-06	1.77e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PPARA—prostate cancer	5.14e-06	1.76e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ITGB3—prostate cancer	5.08e-06	1.74e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—JAK2—prostate cancer	5.06e-06	1.73e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HIF1A—prostate cancer	4.99e-06	1.71e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—JAK2—prostate cancer	4.97e-06	1.7e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PIK3CA—prostate cancer	4.94e-06	1.69e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MDM2—prostate cancer	4.94e-06	1.69e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ERBB3—prostate cancer	4.93e-06	1.69e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FGFR2—prostate cancer	4.92e-06	1.69e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—BCL2—prostate cancer	4.92e-06	1.69e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDKN1B—prostate cancer	4.88e-06	1.67e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—ERBB2—prostate cancer	4.87e-06	1.67e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—LEP—prostate cancer	4.87e-06	1.67e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MDM2—prostate cancer	4.85e-06	1.66e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CAV1—prostate cancer	4.84e-06	1.66e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—IL6—prostate cancer	4.82e-06	1.65e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CAV1—prostate cancer	4.82e-06	1.65e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3CB—prostate cancer	4.81e-06	1.65e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—ERBB2—prostate cancer	4.78e-06	1.64e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL2—prostate cancer	4.78e-06	1.64e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KDR—prostate cancer	4.77e-06	1.63e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTGS2—prostate cancer	4.76e-06	1.63e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PIK3CA—prostate cancer	4.74e-06	1.63e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TERT—prostate cancer	4.73e-06	1.62e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3CB—prostate cancer	4.72e-06	1.62e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ESR1—prostate cancer	4.65e-06	1.59e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.62e-06	1.58e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CTNNB1—prostate cancer	4.61e-06	1.58e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—BAD—prostate cancer	4.53e-06	1.55e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HIF1A—prostate cancer	4.52e-06	1.55e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CDKN1B—prostate cancer	4.51e-06	1.55e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDKN1A—prostate cancer	4.51e-06	1.55e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PTEN—prostate cancer	4.5e-06	1.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—AKT1—prostate cancer	4.45e-06	1.53e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDKN1B—prostate cancer	4.43e-06	1.52e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—LEP—prostate cancer	4.41e-06	1.51e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CG—prostate cancer	4.41e-06	1.51e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CG—prostate cancer	4.39e-06	1.51e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—APC—prostate cancer	4.39e-06	1.51e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—IL6—prostate cancer	4.37e-06	1.5e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CAV1—prostate cancer	4.37e-06	1.5e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EGF—prostate cancer	4.34e-06	1.49e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IRS1—prostate cancer	4.34e-06	1.49e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL2—prostate cancer	4.33e-06	1.49e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KDR—prostate cancer	4.32e-06	1.48e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—EP300—prostate cancer	4.29e-06	1.47e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—AKT1—prostate cancer	4.27e-06	1.47e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CTNNB1—prostate cancer	4.26e-06	1.46e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—GSK3B—prostate cancer	4.21e-06	1.45e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ESR1—prostate cancer	4.21e-06	1.44e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CTNNB1—prostate cancer	4.18e-06	1.43e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—SRC—prostate cancer	4.17e-06	1.43e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—INS—prostate cancer	4.17e-06	1.43e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CDKN1A—prostate cancer	4.16e-06	1.43e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—INS—prostate cancer	4.16e-06	1.43e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTEN—prostate cancer	4.15e-06	1.42e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—BAD—prostate cancer	4.11e-06	1.41e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDKN1A—prostate cancer	4.09e-06	1.4e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CREBBP—prostate cancer	4.08e-06	1.4e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PTEN—prostate cancer	4.08e-06	1.4e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CREBBP—prostate cancer	4.07e-06	1.4e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—AKT1—prostate cancer	4.04e-06	1.38e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—STAT3—prostate cancer	4.02e-06	1.38e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IGF1—prostate cancer	4.02e-06	1.38e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CG—prostate cancer	3.98e-06	1.37e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—APC—prostate cancer	3.98e-06	1.37e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—EP300—prostate cancer	3.96e-06	1.36e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IRS1—prostate cancer	3.94e-06	1.35e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EGF—prostate cancer	3.94e-06	1.35e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—EP300—prostate cancer	3.89e-06	1.33e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MAP2K1—prostate cancer	3.89e-06	1.33e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—AKT1—prostate cancer	3.87e-06	1.33e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CD—prostate cancer	3.87e-06	1.33e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CD—prostate cancer	3.86e-06	1.32e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—SRC—prostate cancer	3.85e-06	1.32e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—GSK3B—prostate cancer	3.82e-06	1.31e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SERPINE1—prostate cancer	3.82e-06	1.31e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—SRC—prostate cancer	3.78e-06	1.3e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—INS—prostate cancer	3.77e-06	1.29e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—STAT3—prostate cancer	3.71e-06	1.27e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FGF2—prostate cancer	3.7e-06	1.27e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CREBBP—prostate cancer	3.69e-06	1.27e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—NOS3—prostate cancer	3.66e-06	1.25e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—EGFR—prostate cancer	3.66e-06	1.25e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—STAT3—prostate cancer	3.65e-06	1.25e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IGF1—prostate cancer	3.65e-06	1.25e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NOS3—prostate cancer	3.65e-06	1.25e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—JAK2—prostate cancer	3.54e-06	1.21e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MAP2K1—prostate cancer	3.52e-06	1.21e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CD—prostate cancer	3.5e-06	1.2e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SERPINE1—prostate cancer	3.46e-06	1.19e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MDM2—prostate cancer	3.46e-06	1.19e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—KRAS—prostate cancer	3.45e-06	1.18e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MYC—prostate cancer	3.45e-06	1.18e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—TGFB1—prostate cancer	3.44e-06	1.18e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ERBB2—prostate cancer	3.41e-06	1.17e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CB—prostate cancer	3.38e-06	1.16e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—EGFR—prostate cancer	3.38e-06	1.16e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CB—prostate cancer	3.37e-06	1.15e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FGF2—prostate cancer	3.35e-06	1.15e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTGS2—prostate cancer	3.34e-06	1.15e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—EGFR—prostate cancer	3.31e-06	1.14e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NOS3—prostate cancer	3.31e-06	1.13e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CXCL8—prostate cancer	3.23e-06	1.11e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—JAK2—prostate cancer	3.21e-06	1.1e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—KRAS—prostate cancer	3.19e-06	1.09e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3CA—prostate cancer	3.17e-06	1.09e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CDKN1B—prostate cancer	3.16e-06	1.08e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MDM2—prostate cancer	3.14e-06	1.08e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—KRAS—prostate cancer	3.13e-06	1.07e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CASP3—prostate cancer	3.1e-06	1.06e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ERBB2—prostate cancer	3.09e-06	1.06e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL2—prostate cancer	3.09e-06	1.06e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CB—prostate cancer	3.05e-06	1.05e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCND1—prostate cancer	3.01e-06	1.03e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CTNNB1—prostate cancer	2.98e-06	1.02e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CXCL8—prostate cancer	2.93e-06	1.01e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3CA—prostate cancer	2.93e-06	1e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MMP9—prostate cancer	2.92e-06	1e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTEN—prostate cancer	2.92e-06	1e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CDKN1A—prostate cancer	2.91e-06	9.99e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTEN—prostate cancer	2.91e-06	9.97e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3CA—prostate cancer	2.88e-06	9.87e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CDKN1B—prostate cancer	2.86e-06	9.82e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL6—prostate cancer	2.81e-06	9.63e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CASP3—prostate cancer	2.81e-06	9.62e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL2—prostate cancer	2.8e-06	9.61e-06	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—EP300—prostate cancer	2.78e-06	9.54e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EP300—prostate cancer	2.77e-06	9.51e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCND1—prostate cancer	2.73e-06	9.37e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CTNNB1—prostate cancer	2.71e-06	9.28e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SRC—prostate cancer	2.7e-06	9.25e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MMP9—prostate cancer	2.65e-06	9.09e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CDKN1A—prostate cancer	2.64e-06	9.06e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTEN—prostate cancer	2.64e-06	9.04e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—VEGFA—prostate cancer	2.63e-06	9.01e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—STAT3—prostate cancer	2.6e-06	8.92e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—IL6—prostate cancer	2.59e-06	8.89e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—AKT1—prostate cancer	2.59e-06	8.89e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL6—prostate cancer	2.55e-06	8.74e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EP300—prostate cancer	2.51e-06	8.62e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SRC—prostate cancer	2.45e-06	8.38e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MYC—prostate cancer	2.42e-06	8.29e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TGFB1—prostate cancer	2.41e-06	8.27e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—AKT1—prostate cancer	2.39e-06	8.21e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—VEGFA—prostate cancer	2.38e-06	8.17e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EGFR—prostate cancer	2.36e-06	8.1e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—STAT3—prostate cancer	2.36e-06	8.09e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—AKT1—prostate cancer	2.35e-06	8.06e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KRAS—prostate cancer	2.23e-06	7.66e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MYC—prostate cancer	2.19e-06	7.51e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TGFB1—prostate cancer	2.19e-06	7.5e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EGFR—prostate cancer	2.14e-06	7.35e-06	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CA—prostate cancer	2.06e-06	7.06e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CA—prostate cancer	2.05e-06	7.03e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KRAS—prostate cancer	2.02e-06	6.94e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TP53—prostate cancer	1.98e-06	6.8e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CA—prostate cancer	1.86e-06	6.38e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL6—prostate cancer	1.82e-06	6.23e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TP53—prostate cancer	1.8e-06	6.17e-06	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—AKT1—prostate cancer	1.68e-06	5.76e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AKT1—prostate cancer	1.68e-06	5.75e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL6—prostate cancer	1.65e-06	5.65e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AKT1—prostate cancer	1.52e-06	5.21e-06	CbGpPWpGaD
